Achieve Life Sciences, Inc. Accounts Payable
Achieve Life Sciences, Inc. (ACHV) had Accounts Payable of $1.94 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-11-06
- 2025-09-30: Accounts Payable, Current $1.94M.
- 2025-06-30: Accounts Payable, Current $1.22M.
- 2025-03-31: Accounts Payable, Current $1.66M.
- 2024-12-31: Accounts Payable, Current $1.95M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2025-09-30 | $1.94M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.22M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.66M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.95M 10-Q · filed 2025-11-06 | |
| 2024-09-30 | $1.01M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $550.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $373.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $618.00K 10-K · filed 2025-03-11 | |
| 2023-09-30 | $638.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $361.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.06M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $1.66M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $412.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $656.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $418.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $841.00K 10-K · filed 2023-03-16 | |
| 2021-09-30 | $815.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $575.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $585.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $332.00K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $326.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $523.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $184.00K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $859.00K 10-K · filed 2021-03-11 | |
| 2019-09-30 | $574.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $707.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $694.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $144.00K 10-K · filed 2020-03-13 | |
| 2018-09-30 | $458.00K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $251.00K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $420.00K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $213.00K 10-K · filed 2019-03-14 | |
| 2017-09-30 | $495.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $233.00K 10-Q · filed 2017-07-31 | |
| 2017-03-31 | $359.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $95.00K 10-K · filed 2018-03-01 | $2.12M 10-K · filed 2017-02-23 |
| 2016-09-30 | $1.04M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $559.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $592.00K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $1.34M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $1.78M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $302.00K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $988.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $72.00K 10-K · filed 2016-03-09 | |
| 2014-09-30 | $1.56M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $1.34M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $923.00K 10-Q · filed 2014-04-30 | |
| 2013-12-31 | $139.00K 10-K · filed 2015-03-26 | |
| 2013-09-30 | $39.00K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $130.00K 10-Q · filed 2013-08-08 | |
| 2012-12-31 | $1.33M 10-K · filed 2014-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |